Cannabis Rescheduling Decision Delayed Until After The Election
The upcoming decision on the Biden administration’s proposal to reclassify cannabis at a federal level has been effectively delayed until after the election in November.
The upcoming decision on the Biden administration’s proposal to reclassify cannabis at a federal level has been effectively delayed until after the election in November.
In the run up to the November election, cannabis companies are spending more than ever to win friends and influence lawmakers in the USA. In the first half of 2024, approximately $4 million has been spent compared to just $2.4 million in the same period of 2023.
NORML’s Deputy Director Paul Armentano said: “Hundreds of thousands of Americans unduly carry the burden and stigma of a past conviction for behavior that most Americans, and a growing number of states, no longer consider to be a crime.
The passage of the SAFER Banking Act would enable financial institutions to expand their offerings as cannabis businesses would have access to capital, banking services, and payment methods that will benefit the entire industry.
The Netherlands starting clinical trials to legalize cannabis has had significant impacts on various fronts. On a social level, it has revitalized debates about the potential benefits and risks associated with cannabis use. The trials have also allowed the government to understand the practical implications of legalization, such as regulating the supply chain, taxation, and public health measures.